In vitro- undersøgelser har vist, at rivaroxaban er et substrat af transportproteinerne P- gp (P - glycoprotein) og Bcrp (brystcancer- resistensprotein).
Based on in vitro investigations rivaroxaban is a substrate of the transporter proteins P-gp (P-glycoprotein) and Bcrp (breast cancer resistance protein).